Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Onset of Heart Failure”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT00524433
What this trial is testing

Tezosentan in the Treatment of Acute Heart Failure

Who this might be right for
Acute Heart FailureAcute Decompensation of Chronic Heart FailureNew Onset of Heart Failure
Idorsia Pharmaceuticals Ltd. 713
Not applicableWithdrawnNCT05870709
What this trial is testing

Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

Who this might be right for
Heart Failure
Novartis Pharmaceuticals
Not applicableUnknownNCT05654792
What this trial is testing

Prognostic Factors in NOP-LBBB After TAVI

Who this might be right for
Transcatheter Aortic Valve Replacement
Central Hospital, Nancy, France 230
Large-scale testing (Phase 3)Study completedNCT00525707
What this trial is testing

Tezosentan in Acute Heart Failure

Who this might be right for
Acute Heart FailureAcute Decompensation of Chronic Heart FailureNew Onset of Heart Failure
Idorsia Pharmaceuticals Ltd. 735
Not applicableStudy completedNCT02700880
What this trial is testing

LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry

Who this might be right for
Ischemic Heart Failure
Zoll Medical Corporation 250
Not applicableLooking for participantsNCT06949319
What this trial is testing

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New Onset+4 more
Nedim Tojaga 150
Large-scale testing (Phase 3)UnknownNCT05556044
What this trial is testing

Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction

Who this might be right for
Acute Heart Failure
Chinese University of Hong Kong 200
Not applicableNot Yet RecruitingNCT07547449
What this trial is testing

Bachmann Bundle Pacing for Prevention of New-Onset Atrial Fibrillation in Patients With Heart Failure

Who this might be right for
Heart FailureAtrial Fibrillation (AF)Cardiac Insufficiency
Fu Wai Hospital, Beijing, China 140